Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12077571 Polyomavirus neutralizing antibodies

Patent 12077571 was granted and assigned to Novartis on September, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Johanna Abend0

Mark Knapp0

Steven Kovacs0

Zorica Dragic0

Adam Lloyd Feire0

Yongqiang Wang0

Danqing Wu0

Fangmin Xu0

...

Date of Patent

September 3, 2024

0

Patent Application Number

181860640

Date Filed

March 17, 2023

0

Patent Citations

US Patent 10011648 Human monoclonal antibody against the VP1 protein of JC virus

0

US Patent 10435460 Polyomavirus neutralizing antibodies

0

US Patent 10450365 Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases

0

US Patent 10450366 Polyomavirus neutralizing antibodies

0

US Patent 10654914 Polyomavirus neutralizing antibodies

0

US Patent 11161894 Polyomavirus neutralizing antibodies

0

US Patent 11639378 Polyomavirus neutralizing antibodies

0

US Patent 11433132 Polyomavirus neutralizing antibodies

0

...

Patent Primary Examiner

0

Patent abstract

The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12077571 Polyomavirus neutralizing antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool